AKT1 and head and neck squamous cell carcinoma: To investigate the mechanism by which CYH33 exhibits its anti-HNSCC activity, we interrogated the effect of CYH33 on the PI3K/Akt signaling in representative sensitive and resistant cells originated from different tissues.